Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Area NEM :: Medical science :: Human medicine
 
Chao-Zong Liu, Mei-Hsu Shih, Pei-Jane Tsai

ClfA221550, a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function

Clumping factor A (ClfA) is a surface protein of Staphylococcus aureus bacteria known for its ability to bind the C-terminus of plasma fibrinogen chain, which participates in mediating fibrinogen-platelet interaction and fibrin cross-linking, resulting in thrombus formation. With an aim to develop agents that block fibrinogen chain C-terminus, the fibrinogen-binding segment of ClfA locating at residues 221550 was produced by recombinant technology and tested for its ability to inhibit platelet functions and fibrin clot formation. Recombinant ClfA221550 bound fibrinogen and blocked fibrinogen-platelet interaction, resulting in the inhibition of both ADP- and collagen-induced platelet aggregations. ClfA221550 also affected fibrin clot formation, in which factor XIIIa-mediated cross-linking of fibrinogen chains was abrogated by ClfA221550 leaving the release of fibrinopeptides A and B from fibrinogen by thrombin unaltered, indicating that ClfA221550 interfered with fibrin clot formation without affecting thrombins catalytic activity. Plateletmediated clot retraction depends on both platelet-fibrinogen interaction and fibrin clot formation, which makes platelet thrombus less susceptible to fibrinolysis. At the concentration that reduced platelet aggregation by 40%, ClfA221550 prevented platelet-mediated clot retraction, whereas the glycoprotein IIb/IIIa antagonist tirofiban needed a higher concentration in inhibiting clot retraction than inhibiting platelet aggregation. By virtue of the multiple effects of ClfA221550 on platelet aggregation, fibrin clot formation and platelet-mediated clot retraction, the binding of ClfA221550 to fibrinogen merits further investigation for its potential as a new antithrombotic agent.

Thrombosis and Haemostasis, Schattauer

Print ISSN: 0340-6245
Volume: 94
Pages: 286 - 294

Show full article (external site)

Show all available items of this journal